Ethinyl Estradiol, Drospirenone, and Levomefolate and Ranibizumab ophthalmic
Determining the interaction of Ethinyl Estradiol, Drospirenone, and Levomefolate and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: drospirenone / ethinyl estradiol / levomefolate calcium
Brand name: Beyaz, Safyral, Rajani, Tydemy
Synonyms: Drospirenone, ethinyl estradiol, and levomefolate
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine Capsule
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine Hydrochloride
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine Injection
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine Suspension
- Ethinyl Estradiol, Drospirenone, and Levomefolate-Ranitidine Syrup
- Ranibizumab ophthalmic-Ethinyl estradiol, folic acid, and levonorgestrel
- Ranibizumab ophthalmic-Ethinyl Estradiol, Norethindrone, and Ferrous Fumarate
- Ranibizumab ophthalmic-Ethiodized oil Injection
- Ranibizumab ophthalmic-Ethiodol
- Ranibizumab ophthalmic-Ethionamide
- Ranibizumab ophthalmic-Ethmozine